AlphAIAlphAI — Financial news for AI agents
stocktitan.netSEP 101 min read$FTRE

Stock sale by former Fortrea (FTRE) officer includes shares to cover taxes

Former Fortrea (FTRE) officer Jill G. McConnell filed a Rule 144 notice to sell 1,071 shares, valued at $17,699.88, including shares to cover taxes from a vested equity award. She previously sold 4,892 shares for $88,975.21 and 1,051 shares for $17,705.57 in the prior three months. The shares were acquired through restricted stock vesting as compensation.

Original reporting
stocktitan.net
Published Sep 10, 2026, 7:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 11:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$FTRE
Neutral
high confidence
Mentioned
$FTRE
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$FTRENeutralLow
01

Why it matters

The disclosed sale is modest and unlikely to affect FTRE's stock price or investor sentiment.

02

Market read

Minor insider sale with limited market relevance.

03

What to watch

Potential upcoming dilution or secondary offerings could affect future perception.

Relevance 4/10Novelty 2/10Timing: September 10, 2026

Background

Rule 144 filings disclose planned sales of restricted securities, often for tax or liquidity reasons.

Company-level read

Ticker impact

$FTRENeutralHigh confidence
Context

Former officer filed a Rule 144 notice to sell 1,071 shares of FTRE stock on Sep 10, 2026.

Expected impact

No material movement expected.

Evidence & confidence

The transaction size is minimal and typical for tax-cover sales; market participants usually ignore such filings.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

Even small insider sales can signal insider confidence, but here the sale is for tax purposes.

Key entities

  • Company
    Fortrea Holdings Inc.

    Issuer of the shares being sold.

  • Individual
    Jill G. McConnell

    Former officer filing the Rule 144 notice.

Read at source← All news

Related articles

SEP 2
$FTREMed

Fortrea (FTRE) Stock Is Up, What You Need To Know

Fortrea Holdings (FTRE) shares rose 2.8% after acquiring Worldwide Clinical Trials' Early Phase Services division, expanding its clinical research capabilities. The acquisition includes facilities in Texas. Fortrea's stock is volatile, with a 52-week high of $20.70. Q3 revenue was $701.3M, beating estimates, but earnings missed. Full-year revenue guidance was raised to $2.73B.

financialcontent.com2 min
SEP 2
$FTREHigh

Fortrea To Acquire Early Phase Services From Worldwide Clinical Trials; Stock Up

Fortrea Holdings (FTRE) agreed to buy the Early Phase Services division of Worldwide Clinical Trials, including labs and clinical units in Texas. The deal expands Fortrea's early development network, adding bioanalytical and clinical pharmacology capabilities. FTRE shares rose 5.98% to $18.78. According to the company, the acquisition supports growth and increases long-term shareholder value.

rttnews.com2 min
SEP 2
$FTREMed

Fortrea Holdings Inc: Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials

Fortrea (FTRE) will acquire Worldwide Clinical Trials' Early Phase Services division for $45M, including a bioanalytical lab and clinical pharmacology unit. The deal expands Fortrea's early clinical development capabilities, enhancing its platform for Phases I-IV studies. Worldwide will focus on its late-stage business. The transaction is subject to regulatory approvals.

finanznachrichten.de2 min